Highlights the achievements made possible through the support of Technion’s donors, partners and community.
Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early‑stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short‑ and long‑term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit, and which are not.
Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early‑stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short‑ and long‑term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit, and which are not.
The Ruth and Bruce Rappaport Faculty of Medicine inaugurated a new complex for its Teaching and Medical Education Division, established through the generous contribution of Professor Emeritus John Finberg — one of the faculty’s veterans and a co-developer of the first-ever drug shown to slow the progression of Parkinson’s disease.
The latest impact report reveals how the Technion Reservist Fund aids student-reservists – granting them flexible study options, counseling, financial relief, and campus security during and after their service.
The Bruce and Ruth Rappaport Foundation has made a transformational gift to Technion for the establishment of the Rappaport Integrative Cancer Research Center and the Rappaport Building for Advanced Medical Research adjacent to the Ruth and Bruce Rappaport Faculty of Medicine. The cornerstone-laying ceremony for
Thanks to generous gifts from our community, we’ve raised over $8,000 to support the important Pancreatic Cancer research – make a gift today and continue supporting this important cause. The Problem Cancer is Australia’s leading cause of burden of disease. Pancreatic Cancer is considered among the deadliest
